首页> 外国专利> CELL PERMEABLE P66SHC FUSION PROTEIN HAVING ANTI-CANCER ACTIVITY

CELL PERMEABLE P66SHC FUSION PROTEIN HAVING ANTI-CANCER ACTIVITY

机译:具有抗癌活性的细胞渗透性P66SHC融合蛋白

摘要

A cell penetrating fusion protein Tat-p66shc, a gene coding the fusion protein, an expression vector containing the gene, and the transformed E. coli are provided to obtain the fusion protein having the anticancer activity. A cell penetrating fusion protein Tat-p66shc is the fusion protein that the human p66shc protein is fused with the protein transduction domain of the Tat protein, and is represented by the sequence number 1. Preferably the gene coding the fusion protein Tat-p66shc is represented by the sequence number 2. The E. coli transformed by the expression vector containing the gent is deposited (deposition number KCTC 11138BP).
机译:提供细胞穿透融合蛋白Tat-p66shc,编码该融合蛋白的基因,包含该基因的表达载体和转化的大肠杆菌,以获得具有抗癌活性的融合蛋白。穿透细胞的融合蛋白Tat-p66shc是人p66shc蛋白与Tat蛋白的蛋白转导域融合的融合蛋白,由序列号1表示。优选地,编码融合蛋白Tat-p66shc的基因表示序列号为2的大肠杆菌。被含gent的表达载体转化的大肠杆菌被保藏(保藏号为KCTC 11138BP)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号